Our results show that FK-3000 decreased levels of phosphorylated CDC25B (phospho-CDC25B) but neither CDC25A nor CDC25C, and induced G2/M phase arrest in human breast carcinoma cell lines MDA-MB231 and MCF-7. Here, CDC25B is linked to breast carcinoma.